News Tocilizumab Offers Durable Response in Steroid-Resistant TED by Medscape • 2025/11/12 • 0 Comments More than half of patients with moderate-to-severe thyroid eye disease who do not improve with corticosteroids achieve disease control after 6 months of treatment with tocilizumab. Medscape Medical News